Mark Schneider, Ph.D.
Affiliations: | 2004 | Queen's University, Canada, Kingston, Ontario, Canada |
Area:
BiochemistryGoogle:
"Mark Schneider"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael E. Nesheim | grad student | 2004 | Queen's University, Canada | |
| (A study of the mechanisms regulating fibrinolysis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Neill EK, Stewart RJ, Schneider MM, et al. (2004) A functional assay for measuring activated thrombin-activatable fibrinolysis inhibitor in plasma. Analytical Biochemistry. 330: 332-41 |
| Schneider M, Nesheim M. (2004) A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. The Journal of Biological Chemistry. 279: 13333-9 |
| Schneider M, Brufatto N, Neill E, et al. (2004) Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin. The Journal of Biological Chemistry. 279: 13340-5 |
| Schneider M, Nesheim M. (2003) Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis. Journal of Thrombosis and Haemostasis : Jth. 1: 147-54 |
| Schneider M, Nagashima M, Knappe S, et al. (2002) Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation. The Journal of Biological Chemistry. 277: 9944-51 |
| Schneider M, Boffa M, Stewart R, et al. (2002) Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. The Journal of Biological Chemistry. 277: 1021-30 |
| Brouwers GJ, Vos HL, Leebeek FW, et al. (2001) A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels. Blood. 98: 1992-3 |
| Wang W, Nagashima M, Schneider M, et al. (2000) Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. The Journal of Biological Chemistry. 275: 22942-7 |
| Black PL, Phillips H, Tribble HR, et al. (1988) Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease. Journal of Cellular Biochemistry. 36: 377-92 |
| Talmadge JE, Schneider M, Lenz B, et al. (1987) Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice Lipids. 22: 871-877 |